Ionis Pharmaceuticals - Crunchbase Company Profile & Funding

Q: How much funding has Ionis Pharmaceuticals raised to date?

Ionis Pharmaceuticals has raised obfuscated.

Overview

Ionis Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ionis Pharmaceuticals

CB Rank

15199

Ionis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs.

Founded

obfuscation

Public

Post-IPO Debt

Carlsbad, California, United States

1001-5000

www.ionispharma.com

Biotechnology

Health Care

Medical

Pharmaceutical

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Key People

Meghdad Rahdar: Assistant Director
Past Role: Ionis Pharmaceuticals, Senior Scientist
Brent Golec: Executive Director, Pharmaceutical Development

Details

Legal Name

Ionis Pharmaceuticals, Inc.

Also Known As

Isis Pharmaceuticals

Operating Status

Active

Number of Exits

obfuscation

Stock Symbol

NASDAQ:IONS

Company Type

For Profit

Founders

Christopher K. Mirabelli, Daniel Ripley

About the Company

Ionis Pharmaceuticals is a pharmaceutical company. It specializes in RNA-targeted drug discovery and development. Ionis has developed antisense technology, an efficient, broadly applicable drug discovery platform that can treat diseases where no other therapeutic approaches have proven effective.

Phone Number

(760)931-9200

Predictions & Insights

Growth Insight

See this Growth Insight

Ionis Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

Antisense Technology

A drug discovery platform that focuses on developing RNA-targeted therapeutics to treat diseases by modulating gene expression.

TEGSEDI (inotersen)

An antisense drug designed to decrease the production of transthyretin protein to treat hereditary ATTR amyloidosis.

Research & Development

Ionis Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Ionis Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Metagenomi	Yes	Corporate Round - Metagenomi	obfuscated obfuscation

Diversity Investments

Number of Diversity Investments

Announced Date	Organization Name	Diversity Spotlight	Funding Round	Money Raised
obfuscated obfuscation	Metagenomi	Women Founded	Corporate Round - Metagenomi	obfuscated obfuscation
obfuscated obfuscation	Aro Biotherapeutics	Women Founded	Series A - Aro Biotherapeutics	obfuscated obfuscation